Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2766]
Articles [207]
Editorials [1]
Conferences [136]
elearning [13]
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of ALK rearranged lung cancer treatment
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of ALK rearranged lung cancer treatment
ESMO 2016: Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression
ESMO 2016: Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1...
ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer
ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer
ESMO 2016: Significant survival gains with atezolizumab vs docetaxel for non-small-cell lung cancer
ESMO 2016: Significant survival gains with atezolizumab vs docetaxel for non-small-cell lung cancer
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
ESMO 2016: Immunotherapy shows promising results in first and second line treatment of metastatic bladder cancer
ESMO 2016: Immunotherapy shows promising results in first and second line treatment of metastatic bladder cancer
ESMO 2016: Frontline PARP inhibitor shrinks tumours in BRCA-positive breast patients
ESMO 2016: Frontline PARP inhibitor shrinks tumours in BRCA-positive breast patients
MicroRNA specifically kills cancer cells with common mutation
MicroRNA specifically kills cancer cells with common mutation
Antibody drug conjugates may help personalise radiotherapy for patients with cancer
Antibody drug conjugates may help personalise radiotherapy for patients with cancer
Chromosomal instability score may predict response to cancer treatment
Chromosomal instability score may predict response to cancer treatment

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation